Queen's Gazette | Queen's University

Search form

Partnership for health innovation

An evolution of the Human Mobility Research Centre, the Centre for Health Innovation connects researchers from across disciplines to tackle the most pressing human health challenges.

Cancer, infectious diseases, health data, and personalized care. The biggest challenges for human health can only be addressed by combining a range of expertise and disciplines. To foster these connections, Queen’s and Kingston Health Sciences Centre (KHSC) have partnered on the Centre for Health Innovation (CHI) – an initiative that brings together interdisciplinary investigators to fuel a solutions-based approach to translational health research, applying knowledge generated at the university to improving patient care and health outcomes.   

“CHI integrates insights from the frontlines of care to understand the real-world experiences and needs of patients and healthcare professionals,” says Amber Simpson, director of CHI and Canada Research Chair in Biomedical Computing and Informatics. “We are multidisciplinary because we understand the creative and innovative power of inclusion will forge a path to the next generation of transformative healthcare for all.” Members of the new centre have diverse backgrounds – from expertise in medicine, engineering, science, and technology to the humanities.

Amber Simpson presents at the Innovation for Good Symposium
Amber Simpson welcomes the audience to the first edition of the Innovation for Good Symposium, which celebrates the team work of the Centre for Health Innovation's members.

The Centre for Health Innovation is an evolution of Queen’s Human Mobility Research Centre (HMRC), which connected experts in medicine, engineering, and computer science to develop innovative treatments for bone and joint disorders. CHI will continue this work, while broadening its goals to address other health challenges, like infectious diseases, and using advanced technology to optimize treatment, diagnostics, and patient outcomes through precision medicine.

Solutions-based health research

The CHI team will pursue cost-effective, high-tech solutions that can be implemented within our current healthcare systems. This includes training and mentoring students and post-doctoral fellows in medical informatics, preparing Canada’s healthcare workforce to deal with rapidly growing field of digital health data.

A pivotal new connection spearheaded by CHI is building synergies between artificial intelligence (AI) and cancer research. Queen’s experts are looking at how machine learning techniques and artificial intelligence solutions might help physicians interpret cancer spread through imaging tests like CT scans and make better treatment decisions. While exploring new possibilities brought on by advancing technologies, the CHI team will also investigate the bioethical implications of using AI to predict metastasis and survival probabilities.

Also crucial for the future of the multidisciplinary centre will be the creation of shared facilities amongst the research community. In partnership with the Canadian Cancer Trials Group (CCTG), the Canada Foundation for Innovation, and Queen’s faculty partners including Health Sciences, Arts and Science, and Engineering, CHI will undertake a large-scale expansion of histopathology and biobanking resources at KHSC. This will expand KHSC’s capacity as the home of the CCTG biobanking facility and support research that will help investigators study the pathological basis of diseases.

Innovation for Good

Today and tomorrow (June 6 and 7), researchers are invited to virtually join the “Innovation for Good” symposium, that will kick off the new centre’s activities showcasing innovative, radically collaborative health research occurring across Queen's and KHSC. For more information, download the event’s program. Click here to register and watch the sessions.

CHI is also developing a state-of-the-art genomics facility to allow the complete analyses of the DNA and RNA molecules in an organism. This expansion leverages work throughout the pandemic on sequencing COVID-19 variants of concern for the province as well as long-standing expertise in cancer biomarkers. Through CHI, investigators will have the ability to leverage genomics and histopathology with data science, a winning combination to change patient outcomes.

While CHI’s objectives and mission are firmly planted on the ground, its research goals also aim for the stars. With proximity to clinicians and access to the human tissue bank, an interdisciplinary team is looking at the impacts of space travel on health, including bone loss and aging.

“We expect the shared resources and specialized facilities will allow innovation in precision medicine and digital health, in alignment with private sector interests, informing government policy, and attracting R&D investment”, notes Dr. Simpson. “Building on the work of HMRC, we are establishing an integrated, truly multi-disciplinary facility that we hope will become a province- and nation-wide resource to support health innovation and research. Exciting things are happening and Queen’s and KHSC are proud to be at the forefront.”